Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease

Objective. To identify, evaluate, and synthesize evidence on the predictive power of circulating endothelial progenitor cells (EPCs) in cardiovascular disease, through a systematic review of quantitative studies. Data Sources. MEDLINE was searched using keywords related to “endothelial progenitor c...

Full description

Saved in:
Bibliographic Details
Main Authors: Caterina Oriana Aragona, Egidio Imbalzano, Federica Mamone, Valentina Cairo, Alberto Lo Gullo, Angela D’Ascola, Maria Adriana Sardo, Michele Scuruchi, Giorgio Basile, Antonino Saitta, Giuseppe Mandraffino
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2016/8043792
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558653031317504
author Caterina Oriana Aragona
Egidio Imbalzano
Federica Mamone
Valentina Cairo
Alberto Lo Gullo
Angela D’Ascola
Maria Adriana Sardo
Michele Scuruchi
Giorgio Basile
Antonino Saitta
Giuseppe Mandraffino
author_facet Caterina Oriana Aragona
Egidio Imbalzano
Federica Mamone
Valentina Cairo
Alberto Lo Gullo
Angela D’Ascola
Maria Adriana Sardo
Michele Scuruchi
Giorgio Basile
Antonino Saitta
Giuseppe Mandraffino
author_sort Caterina Oriana Aragona
collection DOAJ
description Objective. To identify, evaluate, and synthesize evidence on the predictive power of circulating endothelial progenitor cells (EPCs) in cardiovascular disease, through a systematic review of quantitative studies. Data Sources. MEDLINE was searched using keywords related to “endothelial progenitor cells” and “endothelium” and, for the different categories, respectively, “smoking”; “blood pressure”; “diabetes mellitus” or “insulin resistance”; “dyslipidemia”; “aging” or “elderly”; “angina pectoris” or “myocardial infarction”; “stroke” or “cerebrovascular disease”; “homocysteine”; “C-reactive protein”; “vitamin D”. Study Selection. Database hits were evaluated against explicit inclusion criteria. From 927 database hits, 43 quantitative studies were included. Data Syntheses. EPC count has been suggested for cardiovascular risk estimation in the clinical practice, since it is currently accepted that EPCs can work as proangiogenic support cells, maintaining their importance as regenerative/reparative potential, and also as prognostic markers. Conclusions. EPCs showed an important role in identifying cardiovascular risk conditions, and to suggest their evaluation as predictor of outcomes appears to be reasonable in different defined clinical settings. Due to their capability of proliferation, circulation, and the development of functional progeny, great interest has been directed to therapeutic use of progenitor cells in atherosclerotic diseases. This trial is registered with registration number: Prospero CRD42015023717.
format Article
id doaj-art-5150a88f3ad845d18ba71eb0823fd3ec
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-5150a88f3ad845d18ba71eb0823fd3ec2025-02-03T01:31:52ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/80437928043792Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular DiseaseCaterina Oriana Aragona0Egidio Imbalzano1Federica Mamone2Valentina Cairo3Alberto Lo Gullo4Angela D’Ascola5Maria Adriana Sardo6Michele Scuruchi7Giorgio Basile8Antonino Saitta9Giuseppe Mandraffino10Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, Gazzi, 98125 Messina, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, Gazzi, 98125 Messina, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, Gazzi, 98125 Messina, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, Gazzi, 98125 Messina, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, Gazzi, 98125 Messina, ItalyDepartment of Biochemical, Physiological and Nutritional Sciences, University of Messina, Via Consolare Valeria, Gazzi, 98125 Messina, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, Gazzi, 98125 Messina, ItalyDepartment of Biochemical, Physiological and Nutritional Sciences, University of Messina, Via Consolare Valeria, Gazzi, 98125 Messina, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, Gazzi, 98125 Messina, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, Gazzi, 98125 Messina, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, Gazzi, 98125 Messina, ItalyObjective. To identify, evaluate, and synthesize evidence on the predictive power of circulating endothelial progenitor cells (EPCs) in cardiovascular disease, through a systematic review of quantitative studies. Data Sources. MEDLINE was searched using keywords related to “endothelial progenitor cells” and “endothelium” and, for the different categories, respectively, “smoking”; “blood pressure”; “diabetes mellitus” or “insulin resistance”; “dyslipidemia”; “aging” or “elderly”; “angina pectoris” or “myocardial infarction”; “stroke” or “cerebrovascular disease”; “homocysteine”; “C-reactive protein”; “vitamin D”. Study Selection. Database hits were evaluated against explicit inclusion criteria. From 927 database hits, 43 quantitative studies were included. Data Syntheses. EPC count has been suggested for cardiovascular risk estimation in the clinical practice, since it is currently accepted that EPCs can work as proangiogenic support cells, maintaining their importance as regenerative/reparative potential, and also as prognostic markers. Conclusions. EPCs showed an important role in identifying cardiovascular risk conditions, and to suggest their evaluation as predictor of outcomes appears to be reasonable in different defined clinical settings. Due to their capability of proliferation, circulation, and the development of functional progeny, great interest has been directed to therapeutic use of progenitor cells in atherosclerotic diseases. This trial is registered with registration number: Prospero CRD42015023717.http://dx.doi.org/10.1155/2016/8043792
spellingShingle Caterina Oriana Aragona
Egidio Imbalzano
Federica Mamone
Valentina Cairo
Alberto Lo Gullo
Angela D’Ascola
Maria Adriana Sardo
Michele Scuruchi
Giorgio Basile
Antonino Saitta
Giuseppe Mandraffino
Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease
Stem Cells International
title Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease
title_full Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease
title_fullStr Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease
title_full_unstemmed Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease
title_short Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease
title_sort endothelial progenitor cells for diagnosis and prognosis in cardiovascular disease
url http://dx.doi.org/10.1155/2016/8043792
work_keys_str_mv AT caterinaorianaaragona endothelialprogenitorcellsfordiagnosisandprognosisincardiovasculardisease
AT egidioimbalzano endothelialprogenitorcellsfordiagnosisandprognosisincardiovasculardisease
AT federicamamone endothelialprogenitorcellsfordiagnosisandprognosisincardiovasculardisease
AT valentinacairo endothelialprogenitorcellsfordiagnosisandprognosisincardiovasculardisease
AT albertologullo endothelialprogenitorcellsfordiagnosisandprognosisincardiovasculardisease
AT angeladascola endothelialprogenitorcellsfordiagnosisandprognosisincardiovasculardisease
AT mariaadrianasardo endothelialprogenitorcellsfordiagnosisandprognosisincardiovasculardisease
AT michelescuruchi endothelialprogenitorcellsfordiagnosisandprognosisincardiovasculardisease
AT giorgiobasile endothelialprogenitorcellsfordiagnosisandprognosisincardiovasculardisease
AT antoninosaitta endothelialprogenitorcellsfordiagnosisandprognosisincardiovasculardisease
AT giuseppemandraffino endothelialprogenitorcellsfordiagnosisandprognosisincardiovasculardisease